Power Law company profile

Aprogen

Biotech & Life Sciences · Seongnam-si, South Korea · Founded 2000 Unicorn

Biologics platform company focused on developing and manufacturing biosimilar products, new protein drugs and bispecific antibodies

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Revenue

$100–500M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Aprogen's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage

Lindeman Asia Investment Corporation

Alpenroute Asset Management

Global footprint

Where Aprogen has talent and traffic

Workforce by country

1 countries with
team presence

🇰🇷 South Korea100%

1 country shown

Web traffic by country

86K monthly visits
across markets

🏳️ Korea99.5%

🏳️ Republic of0%

Top 2 markets shown

Patent intelligence

$23M patent portfolio · 18 active families

Estimated portfolio value

$23M

2.3% of valuation · 2.7× smaller than top peer Sirna Therapeutics ($63M)

18 active patent families

Where Aprogen innovates Nucleic acid moleculeMolecular biologyAntigenAntibodyMonoclonal antibody

Where Aprogen concentrates vs peers

Each axis is a top-10 topic across Aprogen and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Aprogen

An AI-synthesized read of the highest-engagement posts about Aprogen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aprogen on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles